Voyager Therapeutics VYGR Price Prediction

The determination to procure Voyager Therapeutics is entirely contingent on your individualistic risk tolerance. As you may discern, Voyager Therapeutics's value has experienced a fall of -2.48% during the preceding 24 hours, and Voyager Therapeutics has incurred a decline of -14.16% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Voyager Therapeutics will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Voyager Therapeutics may potentially surge to $5.27 by the end of this year. Looking at Voyager Therapeutics's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $5.01. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Voyager Therapeutics forecast, the price of Voyager Therapeutics will fall by -2% over the next week and reach $3.86 by January 23, 2026.

Based on the our new experimental Voyager Therapeutics forecast, the price of Voyager Therapeutics will increase by 3.95% over the next month and reach $4.09 by February 15, 2026.

As per our most recent prediction on Voyager Therapeutics's value in 2026, VYGR is anticipated to fluctuate within the range of $3.86 and $5.27. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Voyager Therapeutics price forecast fails to consider sudden and extreme price fluctuations.

Voyager Therapeutics's future appears to be on an upward trend, with an maximum price of $5.01 projected after a period of five years. Based on the Voyager Therapeutics forecast for 2031, Voyager Therapeutics's value may potentially reach its highest peak of approximately $5.01, while its lowest peak is anticipated to be around $4.47.

Based on the our new experimental Voyager Therapeutics price prediction simulation, VYGR’s value in 2026 expected to grow by 33.92% to $5.27 if the best happened. The price will be between $5.27 and $3.86 during 2026.

According to our latest experimental simulation for Voyager Therapeutics price prediction, VYGR’s value could rise by 41.12% to $5.56 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $5.56 and $4.26 throughout the year.

Our new experimental Voyager Therapeutics price prediction model suggests that VYGR’s value in 2028 could increase by 15.37% , reaching $4.54 in the best-case scenario. The price is expected to range between $4.54 and $3.30 during the year.

Based on our experimental forecast model, Voyager Therapeutics's value may experience a 2.43% growth in 2029, potentially reaching $4.03 under optimal conditions. The predicted price range for 2029 lies between $4.03 and $3.34.

Using our new experimental simulation for Voyager Therapeutics price predictions, VYGR’s value in 2030 is expected to rise by 22.75% , reaching $4.83 in the best scenario. The price is forecasted to range between $4.83 and $3.54 over the course of 2030.

Our experimental simulation indicates that Voyager Therapeutics’s price could grow by 27.21% in 2031, potentially hitting $5.01 under ideal conditions. The price will likely fluctuate between $5.01 and $4.47 during the year.

Based on the findings from our latest experimental Voyager Therapeutics price prediction, VYGR could see a 54.42% rise in value, reaching $6.08 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $6.08 and $4.86 throughout the year.

According to our experimental Voyager Therapeutics price prediction, VYGR’s value is anticipated to rise by 100.65% in 2033, with the highest potential price being $7.90. Throughout the year, VYGR’s price could range from $7.90 and $6.09.

The results from our new Voyager Therapeutics price prediction simulation suggest that VYGR may rise by 133.86% in 2034, potentially reaching $9.21 under the best circumstances. The predicted price range for the year is between $9.21 and $7.64.

Based on our experimental forecast for Voyager Therapeutics’s price, VYGR could grow by 196.93% , with the value potentially hitting $11.69 in 2035. The expected price range for the year lies between $11.69 and $8.64.

Our recent Voyager Therapeutics price prediction simulation suggests that VYGR’s value might rise by 317.46% in 2036, possibly reaching $16.44 if conditions are optimal. The expected price range for 2036 is between $16.44 and $11.09.

According to the experimental simulation, Voyager Therapeutics’s value could rise by 443.12% in 2037, with a high of $21.39 under favorable conditions. The price is expected to fall between $21.39 and $16.12 over the course of the year.